- The Short Answer: Clinical Biochemical Genetics
- What the Specialty Actually Covers
- Who Certifies It: The ABMGG
- The Fifteen Blueprint Categories
- Why the Acronym Causes Confusion
- What Candidates Are Tested On
- Exam Timing and Offering Schedule
- Where Biochemical Geneticists Work
- Sequencing Your Preparation by Domain
- Frequently Asked Questions
- In this context, CBG stands for Clinical Biochemical Genetics, a specialty certified by the ABMGG.
- The blueprint has fifteen content categories, led by Amino acids at about 15 percent.
- Lipids (13%), Organic acids (12%) and Lysosomes (12%) form the next heaviest content areas.
- The next exam is identified as August 2027; biochemical specialties are offered in odd years.
The Short Answer: Clinical Biochemical Genetics
On this site, CBG stands for Clinical Biochemical Genetics. It is a medical genetics subspecialty focused on inherited metabolic disease: the disorders in which a single faulty enzyme, transporter, or cofactor pathway disrupts the body's chemistry. Phenylketonuria, urea cycle defects, fatty acid oxidation disorders, lysosomal storage diseases, and mitochondrial disorders all fall within its scope.
The credential is administered by the American Board of Medical Genetics and Genomics (ABMGG). If you landed here after searching the acronym, it is worth stating plainly that several unrelated credentials and terms share the same three letters. Everything in this article concerns only the biochemical genetics specialty and its ABMGG blueprint. For a broader orientation, our overview pages What Is CBG? and CBG Meaning cover the same ground from different angles.
What the Specialty Actually Covers
Clinical biochemical genetics sits at the intersection of clinical medicine and laboratory science. A biochemical geneticist evaluates patients with suspected metabolic disease, interprets the biochemical testing that reveals the disorder, and helps guide diagnosis, management, and follow-up. That means reading amino acid profiles, organic acid patterns, acylcarnitine results, enzyme assays, and increasingly integrating them with molecular findings.
The discipline is organized around metabolic pathways rather than organ systems. A single patient might present with encephalopathy, hypoglycemia, or developmental regression, and the clinician must work backward from the biochemical signature to the underlying defect. That pathway-first thinking is exactly what the certification blueprint is built to assess.
Who Certifies It: The ABMGG
The American Board of Medical Genetics and Genomics publishes the content outlines and blueprints that define what candidates are expected to know. The biochemical genetics blueprint used for this site is the ABMGG Biochemical Genetics Blueprint and Content Codes, effective August 2025. The ABMGG also publishes its exam scheduling information, including an announced transition toward an annual certifying examination schedule.
Two practical notes follow from that. First, always confirm current details directly with the ABMGG, because blueprints and schedules are revised over time; the board's index has referenced 2026 outlines even while the blueprint we draw on is dated August 2025. Second, details such as fees, question counts, timing, and passing standards should be verified at the source rather than assumed. For eligibility and prerequisites, see CBG Requirements, and for the financial side, CBG Certification Cost.
The Fifteen Blueprint Categories
The blueprint divides the specialty into fifteen content topics, each with an approximate weighting. The published percentages are approximate and, as supplied, add up to slightly more than 100 percent because of a discrepancy in the source; they are best read as relative emphasis, not exact question counts.
| Category | Approx. Weight | Representative Content |
|---|---|---|
| Amino acids | 15% | PKU, tyrosinemias, MSUD, homocystinuria, urea cycle defects |
| Organic acids | 12% | Methylmalonic and propionic acidemia, glutaric acidemia type I, ketone body disorders |
| Cofactors | 7% | Cobalamin, biotin, molybdenum, folate, pyridoxine, biopterin |
| Carbohydrates | 10% | Glycogenoses, galactose and fructose metabolism, congenital disorders of glycosylation |
| Lipids | 13% | Fatty acid oxidation disorders, hyperlipidemias, cholesterol metabolism |
| Lysosomes | 12% | Mucopolysaccharidoses, sphingolipidoses, mucolipidoses, Pompe, cystinosis |
| Mitochondria | 7% | Electron transport chain, mtDNA mutation and maintenance disorders, MELAS |
| Peroxisomes | 3% | Zellweger syndrome, X-linked adrenoleukodystrophy |
| Purines and pyrimidines | 3% | Lesch-Nyhan disease, ADA deficiency, UMP synthase deficiency |
| Transport | 3% | Cystinuria, lysinuric protein intolerance, glucose and carnitine transport |
| Creatine | 1% | Creatine disorders |
| Neurotransmitters | 2% | SSADH deficiency, dopamine synthesis disorders |
| Metals | 3% | Wilson disease, Menkes disease, iron, zinc |
| Laboratory | 8% | QA/QC, artifact, techniques, regulations |
| Other disease category | 3% | Conditions outside the named categories |
For a category-by-category walkthrough, see CBG Exam Domains: Complete Guide to All 15 Content Areas.
The heavyweight domains
Amino acids (15%)
The single largest category, and a natural foundation for everything else in the specialty.
- PKU and hyperphenylalaninemia, plus the tyrosinemias
- Glycine encephalopathy/hyperglycinemia and MSUD (branched-chain amino acid disorders)
- Homocystinuria, sulfur amino acid disorders, and re-methylation defects
- Urea cycle defects, along with serine and other amino acid disorders
Lipids (13%)
Fatty acid oxidation is the centerpiece, but the category is broader than it first appears.
- Short-chain, medium-chain, and long-chain oxidation defects, plus multiple acyl-CoA dehydrogenase deficiency (GA2)
- Hyperlipidemias, including Tangier disease
- Cholesterol metabolism: Smith-Lemli-Opitz, Niemann-Pick C, and bile acid disorders
Organic acids (12%) and Lysosomes (12%)
Together these two categories carry nearly a quarter of the blueprint.
- Organic acids: methylmalonic acidemia (excluding cobalamin defects), propionic acidemia, 3-MCC deficiency and other C5OH-related disorders, IVA, glutaric acidemia type I, ketone body disorders, and entities such as ECHS1 and glutathione synthetase deficiency
- Lysosomes: mucopolysaccharidoses (Types I, II, III, IV, VI, VII), sphingolipidoses (Gaucher, Fabry, Tay-Sachs, Sandhoff, Krabbe, Niemann-Pick A and B, GM1), mucolipidoses, Pompe, cystinosis, and NCL
Why the Acronym Causes Confusion
Searchers frequently arrive at this topic from queries like "what does CBG mean" or "what is a CBG," and results can mix together unrelated fields. This site is about one thing only: the biochemical genetics specialty certified through the ABMGG. If you are comparing information from multiple sources, check that each one actually refers to metabolic genetics before relying on any fee, date, or requirement it lists. Mixing facts across unrelated credentials is one of the most common ways candidates end up with wrong expectations.
Related explainers on this site approach the same question from different search phrasings, including What Does CBG Mean?, What Is CBG Certification?, and CBG Certification.
What Candidates Are Tested On
The blueprint describes content, not question mechanics, and the specific number of questions, time limit, and scoring standard are not established in the source material this site relies on, so we do not state them here. What the blueprint does make clear is the shape of the knowledge required.
Pattern recognition across pathways
Expect to move between a clinical scenario, a biochemical result, and a diagnosis. Knowing that a disorder exists is not enough; you need to know how it presents, which metabolites accumulate, which enzyme or cofactor is implicated, and how that distinguishes it from look-alike conditions. The organic acids category illustrates this: methylmalonic acidemia, propionic acidemia, and the C5-related disorders produce overlapping presentations that are separated by specific laboratory patterns.
The laboratory category is its own domain
At roughly 8 percent, the Laboratory category covers QA/QC, artifact, techniques, and regulations. Candidates who think of themselves as purely clinical sometimes under-prepare here. Recognizing an artifact that mimics a disorder, or understanding why a technique is suited to one analyte and not another, is a distinct skill from recalling disease facts.
For a realistic sense of effort required, read How Hard Is the CBG Exam?, and for scoring questions, CBG Passing Score.
Exam Timing and Offering Schedule
The ABMGG has announced that its 2027 certification exams will take place August 11 to 14, 2027, and the next CBG exam is identified as August 2027. Biochemical specialties are offered in odd years, which is why the gap between administrations matters when you plan a timeline. The board has also approved a transition toward an annual certifying examination schedule, so confirm directly with the ABMGG how that affects the specialty you are targeting before locking in dates.
Because this is not a continuously scheduled, any-day test, planning backward from the administration window is essential. Our CBG Exam Dates page tracks scheduling details, and CBG Certification Cost addresses fee mechanics. We deliberately do not quote a specific fee or passing score here, since those figures were not established from the official source content we rely on.
Where Biochemical Geneticists Work
Certified biochemical geneticists typically work in settings where inherited metabolic disease is diagnosed and managed. Common environments include academic medical centers with metabolic clinics, children's hospitals, and clinical biochemical genetics laboratories. Roles often blend direct patient care with laboratory interpretation and consultation, and some positions include newborn screening follow-up and teaching responsibilities.
We avoid quoting earnings figures because none were established from the source material for this credential. If compensation and career outlook are your main questions, our CBG Salary Guide, Is the CBG Certification Worth It?, and CBG Jobs pages discuss the topic qualitatively and in context.
Sequencing Your Preparation by Domain
If you are building a plan around the blueprint, the weighting and the way the categories build on one another suggest an order. One approach is to start with amino acids because the biochemistry there anchors later material, then branch into organic acids and cofactors, which share metabolic logic. Carbohydrates and lipids follow naturally, with fatty acid oxidation deserving real depth. Lysosomal disorders reward systematic memorization of enzyme-substrate-phenotype relationships, while mitochondrial disease benefits from a firm grasp of the electron transport chain.
Foundations: Amino acids and Organic acids
- Work through PKU, MSUD, homocystinuria, and urea cycle defects
- Pair them with methylmalonic and propionic acidemia and glutaric acidemia type I
Cofactors, Carbohydrates, and Lipids
- Cobalamin, biotin, and biopterin as cross-cutting themes
- Glycogenoses, galactose and fructose disorders, and fatty acid oxidation defects
Lysosomes, Mitochondria, and the long tail
- Mucopolysaccharidoses and sphingolipidoses
- Electron transport chain disorders, peroxisomes, purines, transport, metals
Laboratory and integration
- QA/QC, artifact, techniques, and regulations
- Mixed case review across all fifteen categories
Smaller categories such as Creatine (1%), Neurotransmitters (2%), and Peroxisomes (3%) are easy to neglect, but they are also where focused review can pay off quickly because the content is compact. For a fuller plan, see the CBG Study Guide, the one-page CBG Cheat Sheet, and our overview of CBG Training.
Key Takeaway
Use the blueprint weights to allocate time, but do not skip small categories. A topic worth only a few percent of the exam is still a reliable source of points if you have reviewed it, and it is exactly where unprepared candidates lose them. Test yourself with timed practice at our practice test site to find weak domains early.
Frequently Asked Questions
On this site, CBG stands for Clinical Biochemical Genetics, a medical genetics specialty concerned with inherited metabolic disorders. The certification is administered by the American Board of Medical Genetics and Genomics (ABMGG).
No. The acronym is shared by unrelated terms and credentials. Everything here refers only to the ABMGG biochemical genetics specialty, so do not apply fees, dates, or requirements from other fields to it.
The ABMGG Biochemical Genetics Blueprint effective August 2025 lists fifteen content categories, from Amino acids at roughly 15 percent down to Creatine at roughly 1 percent. The published percentages are approximate and sum to slightly over 100 percent in the source.
The next exam is identified as August 2027, and biochemical specialties are offered in odd years. The ABMGG has also announced a transition toward an annual certifying schedule, so verify current timing directly with the board.
The ABMGG publishes content outlines and blueprints on its website under initial certification. The biochemical genetics blueprint is the authoritative list of exam topics, and it is worth reading alongside broader study resources. See our What Does CBG Stand For? and What Is A CBG? pages for related explanations.